Mismatch Repair Deficient (dMMR) clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
open to eligible people ages 18 years and up
The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of INCB 99280 in combination with ipilimumab in participants with select solid tumors.
Orange, California and other locations
Last updated: